Difficulty: Medium
Average Score: 74%
Practice
A 10-mo-old boy has a left suprarenal mass. Surgery is accomplished with complete removal of the mass as well as the non-adherent lymph nodes; surgical biopsies are taken during surgery. The histology reveals poorly differentiated neuroblastoma with microscopic ipsilateral lymph nodes involvement. The contralateral lymph nodes are negative. Of the following, the BEST therapeutic approach for this infant is
Correct answer
A
Rationale
The BEST therapeutic approach for the infant with poorly differentiated neuroblastoma and ipsilateral lymph node involvement is chemotherapy (Option A). Neuroblastoma in infants often presents as a highly malignant tumor, and chemotherapy is the primary treatment modality for disseminated disease. In this case, with microscopic lymph node involvement, systemic treatment like chemotherapy is crucial to target potential metastatic disease.
Option B (radiotherapy) is not the best initial therapy for neuroblastoma in infants due to their young age and the potential for long-term side effects on developing tissues. Option C (concomitant chemo-radiotherapy) is not typically used as the primary treatment for neuroblastoma. Option D (chemotherapy followed by radiotherapy) may be considered in cases with high-risk features post-chemotherapy, but initial treatment for an infant with neuroblastoma and lymph node involvement would still be chemotherapy.
Educationally, understanding the rationale behind treatment decisions in pediatric oncology is vital for nurses caring for pediatric oncology patients. Chemotherapy is often the cornerstone of treatment for pediatric malignancies, and knowing the appropriate sequencing and combination of therapies is crucial for providing safe and effective care to these vulnerable patients.
Option B (radiotherapy) is not the best initial therapy for neuroblastoma in infants due to their young age and the potential for long-term side effects on developing tissues. Option C (concomitant chemo-radiotherapy) is not typically used as the primary treatment for neuroblastoma. Option D (chemotherapy followed by radiotherapy) may be considered in cases with high-risk features post-chemotherapy, but initial treatment for an infant with neuroblastoma and lymph node involvement would still be chemotherapy.
Educationally, understanding the rationale behind treatment decisions in pediatric oncology is vital for nurses caring for pediatric oncology patients. Chemotherapy is often the cornerstone of treatment for pediatric malignancies, and knowing the appropriate sequencing and combination of therapies is crucial for providing safe and effective care to these vulnerable patients.